GlobeNewswire Inc.··World Street Intelligence News CommentaryCold Tumors Heat Up: New Immunotherapy Wave Targets Resistant Cancers
Novel immune-priming therapies targeting treatment-resistant solid tumors advance through trials in 2026, with $1.7B in dealmaking across four mechanistic approaches.
VIRSNSEONCYGTBPclinical trialssolid tumors